Lindsay Richardson
Family · Marietta, GANPI 1528481637
Payments from drug & device makers
Across 325 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Amgen$618
- AbbVie$517
- Boehringer Ingelheim$419
- Lilly USA, LLC$346
- Sanofi-aventis U.S. LLC$309
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,572100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 77 | $1,231 |
| Amgen | 43 | $618 |
| AbbVie | 33 | $517 |
| Boehringer Ingelheim | 22 | $419 |
| Lilly USA, LLC | 20 | $346 |
| Sanofi-aventis U.S. LLC | 14 | $309 |
| GSK | 17 | $273 |
| Abbott | 12 | $244 |
| Astellas Pharma US Inc | 10 | $226 |
| Merck | 10 | $192 |
| Dexcom, Inc. | 8 | $168 |
| Novartis | 7 | $152 |
| Bayer | 7 | $140 |
| Exact Sciences | 9 | $132 |
| Dynavax Technologies Corporation | 5 | $117 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $88 |
| Amarin Pharma, Inc. | 5 | $82 |
| AstraZeneca | 4 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Pfizer | 2 | $27 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$5,572 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 75 | $99,238 |
| JanuviaSitagliptin Phosphate | 55 | $58,919 |
| JardianceEmpagliflozin | 36 | $44,398 |
| ProliaDenosumab | 25 | $42,975 |
| FarxigaDapagliflozin Propanediol | 23 | $29,089 |
| MounjaroTirzepatide | 20 | $26,933 |
| EliquisApixaban | 28 | $20,925 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $11,714 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,972 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $3,156 |
| Levothyroxine Sodium | 293 | $2,839 |
| Atorvastatin Calcium | 362 | $2,649 |
| SynthroidLevothyroxine Sodium | 35 | $2,005 |
| Rosuvastatin Calcium | 134 | $1,307 |
| Gabapentin | 86 | $1,296 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,231 | $99,23875 claims |
| MerckJanuvia | $192 | $58,91955 claims |
| Boehringer IngelheimJardiance | $419 | $44,39836 claims |
| AmgenProlia | $618 | $42,97525 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $55 | $39,21748 claims |
| Lilly USA, LLCMounjaro | $346 | $26,93320 claims |
| PfizerEliquis | $27 | $20,92528 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $309 | $11,71412 claims |
| AbbVieSynthroid | $517 | $2,00535 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Marietta
- Allie McAllisterMarietta$299K
- Lori ReedMarietta$106K
- Jennifer MekhoukhMarietta$38K
- Janie DinhMarietta$14K
- Erin EsfahaniMarietta$14K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.